Table 2.
SEP parameters for the different groups.
| HC n = 45 | Bip n = 25 | HR n = 59 | UHR n = 73 | Fa | ES (r) | rb | ||
|---|---|---|---|---|---|---|---|---|
| N20 | Strengthb | −9.67 (4.4) | −12.42 (6.3) | −8.68 (4.2) | −8.53 (4.0) | 5.23*** | 0.86 | 0.74 |
| Latencyc | 19.06 (1.5) | 19.02 (1.5) | 19.67 (1.3) | 19.41 (1.3) | 2.23 | |||
| N20-P25 | Strengthb | 24.42 (9.2) | 26.87 (11.1) | 21.35 (8.3) | 21.37 (8.7) | 3.30* | 0.21 | 0.04 |
| HFO early | Amplitudeb | 1.58 (0.9) | 1.86 (0.9) | 1.19 (0.7) | 1.32 (0.8) | 4.91*** | 0.27 | 0.07 |
| Latency | 17.90 (1.5) | 18.05 (1.0) | 18.27 (1.5) | 18.08 (1.4) | 0.60 | |||
| HFO late | Amplitudeb | 1.52 (0.9) | 1.78 (0.9) | 1.17 (0.6) | 1.24 (0.7) | 4.58*** | 0.26 | 0.07 |
| Latency | 19.88 (1.7) | 19.86 (0.9) | 19.97 (3.0) | 20.40 (1.4) | 0.87 |
a
p < 0.05*, p < 0.005***.
b
in nAm.
c
in ms. HC, healthy controls; Bip, at-risk-bipolar; HR, high-risk; UHR, ultra-high-risk; ES, effect size.